Nexium Buyers Say Ranbaxy Should Turn Over Docs In MDL
Direct-purchaser plaintiffs in the pay-for-delay multidistrict litigation involving the heartburn drug Nexium on Tuesday asked a Massachusetts federal judge to compel generic-drug maker Ranbaxy Inc. to carry out supplemental production of...To view the full article, register now.
Already a subscriber? Click here to view full article